(Q34264021)

1 August 2017

1 reference

title

LYVE-1, the lymphatic system and tumor lymphangiogenesis (English)

1 reference

1 August 2017

1 reference

Jackson DG

1

1 reference

1 August 2017

Prevo R

series ordinal

2

1 reference

1 August 2017

Clasper S

series ordinal

3

1 reference

1 August 2017

Banerji S

series ordinal

4

1 reference

1 August 2017

1 June 2001

1 reference

1 August 2017

1 reference

1 August 2017

22

1 reference

1 August 2017

317-321

1 reference

1 August 2017

6

1 reference

LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

Hyaluronan: a multifunctional, megaDalton, stealth molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

Anti-CD44 treatment abrogates tissue aedema and leukocyte infiltration in murine arthrtis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

Administration of antibodies to hyaluronanreceptor (CD44) delays the start and ameliorates the severity of collagen II arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

Requirement for CD44 in activated T cell extravasation into an inflammatory site

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

Angiogenesis induced by degradation products of hyaluronic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

Uptake and degradation of hyaluronan in lymphatic tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

Solution structure of the link module: a hyaluronan-binding domain involved in extracellular matrix stability and cell migration

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

The protein fold of the hyaluronate-binding proteoglycan tandem repeat domain of link protein, aggrecan and CD44 is similar to that of the C-type lectin superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

CD44 in inflammation and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

CD44 is the principal cell surface receptor for hyaluronate

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

Identification of hyaluronic acid binding sites in the extracellular domain of CD44

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

Identification of CD44 residues important for hyaluronan binding and delineation of the binding site

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

Characterization of a functional hyaluronan-binding domain from the human CD44 molecule expressed in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

The importance of cellular environment to function of the CD44 matrix receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

Inhibition of hyaluronan uptake in lymphatic tissue by chondroitin sulphate proteoglycan

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901936-6

7 January 2021

10.1016/S1471-4906(01)01936-6

Identifiers

DOI

1 reference

1 August 2017

1 reference